It has been shown that HIF-1-mediated VEGF expression plays an important role in the formation of novel blood vessels, therefore, angiogenesis inhibitors that inhibit the expression of HIF-1α and VEGF have been widely studied for the treatment of human cancers [30, 31]. Here, VEGFA is linked to cancer.